Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(5), P. 1825 - 1833
Published: Jan. 26, 2024
Cancer
onset
and
progression
are
known
to
be
regulated
by
genetic
epigenetic
events,
including
RNA
modifications
(a.k.a.
epitranscriptomics).
So
far,
more
than
150
chemical
have
been
described
in
all
subtypes,
messenger,
ribosomal,
transfer
RNAs.
their
regulators
implicated
steps
of
post-transcriptional
regulation.
The
dysregulation
this
complex
yet
delicate
balance
can
contribute
disease
evolution,
particularly
the
context
carcinogenesis,
where
cells
subjected
various
stresses.
We
sought
discover
involved
cancer
cell
adaptation
inhospitable
environments,
a
peculiar
feature
stem
(CSCs).
were
interested
marks
that
help
suspension
culture,
which
is
often
used
as
surrogate
evaluate
tumorigenic
potential.
For
purpose,
we
designed
an
experimental
pipeline
consisting
four
steps:
(1)
culture
different
growth
conditions
favor
CSC
survival;
(2)
simultaneous
subtype
(mRNA,
rRNA,
tRNA)
enrichment
hydrolysis;
(3)
multiplex
analysis
nucleosides
LC-MS/MS
followed
statistical/bioinformatic
analysis;
(4)
functional
validation
identified
marks.
This
study
demonstrates
modification
landscape
evolves
along
with
phenotype
under
constraints.
Remarkably,
discovered
short
epitranscriptomic
signature,
conserved
across
colorectal
lines
associated
CSCs.
Functional
tests
confirmed
importance
selected
process
confirming
validity
our
approach
opening
up
interesting
prospects
field.
Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
300(4), P. 106793 - 106793
Published: Feb. 24, 2024
RNA
5-methylcytosine
(m5C)
is
an
abundant
chemical
modification
in
mammalian
RNAs
and
plays
crucial
roles
regulating
vital
physiological
pathological
processes,
especially
cancer.
However,
the
dysregulation
of
m5C
its
underlying
mechanisms
non-small
cell
lung
cancer
(NSCLC)
remain
unclear.
Here
we
identified
that
NSUN2,
a
key
methyltransferase,
highly
expressed
NSCLC
tumor
tissue.
We
found
elevated
NSUN2
expression
levels
strongly
correlate
with
grade
size,
predicting
poor
outcomes
for
patients.
Furthermore,
RNA-seq
subsequent
confirmation
studies
revealed
antioxidant-promoting
transcription
factor
NRF2
target
depleting
decreases
increases
sensitivity
cells
to
ferroptosis
activators
both
vitro
vivo.
Intriguingly,
methylated-RIP-qPCR
assay
results
indicated
mRNA
has
higher
level
when
overexpressed
but
shows
no
significant
changes
methyltransferase-deficient
group.
Mechanistically,
confirmed
upregulates
by
enhancing
stability
through
within
5'UTR
region
recognized
specific
reader
protein
YBX1,
rather
than
influencing
translation.
In
rescue
experiments,
show
knocking
down
diminished
proliferation,
migration,
tolerance
mediated
overexpression.
conclusion,
our
study
unveils
novel
regulatory
mechanism
which
sustains
m5C-YBX1-axis,
suggesting
targeting
regulated
pathway
might
offer
promising
therapeutic
strategies
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 30, 2024
Drug
resistance
in
cancer
cells
significantly
diminishes
treatment
efficacy,
leading
to
recurrence
and
metastasis.
A
critical
factor
contributing
this
is
the
epigenetic
alteration
of
gene
expression
via
RNA
modifications,
such
as
N6-methyladenosine
(m6A),
N1-methyladenosine
(m1A),
5-methylcytosine
(m5C),
7-methylguanosine
(m7G),
pseudouridine
(Ψ),
adenosine-to-inosine
(A-to-I)
editing.
These
modifications
are
pivotal
regulating
splicing,
translation,
transport,
degradation,
stability.
Governed
by
"writers,"
"readers,"
"erasers,"
impact
numerous
biological
processes
progression,
including
cell
proliferation,
stemness,
autophagy,
invasion,
apoptosis.
Aberrant
can
lead
drug
adverse
outcomes
various
cancers.
Thus,
targeting
modification
regulators
offers
a
promising
strategy
for
overcoming
enhancing
efficacy.
This
review
consolidates
recent
research
on
role
prevalent
resistance,
with
focus
m6A,
m1A,
m5C,
m7G,
Ψ,
A-to-I
Additionally,
it
examines
regulatory
mechanisms
linked
underscores
existing
limitations
field.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Aug. 4, 2023
Lung
cancer
is
the
leading
cause
of
cancer-related
deaths
worldwide.
Long
non-coding
RNAs
(lncRNAs)
have
emerged
as
key
regulators
development
and
progression,
promising
biomarkers
for
diagnosis
prognosis
cancer.
In
this
study,
we
identified
a
new
lncRNA
(LINC02159)
that
was
upregulated
in
tumor
tissues
serum
non-small
cell
lung
(NSCLC)
patients.
We
demonstrated
knockdown
LINC02159
inhibited
NSCLC
proliferation,
migration,
invasion,
but
induced
apoptosis
cycle
arrest
vitro
retarded
growth
vivo,
while
overexpression
led
to
opposite
effect.
discovered
highly
correlated
with
metastasis-related
pathways
by
using
transcriptomic
analysis
YAP1
potential
target
gene
LINC02159.
Mechanistically,
bound
Aly/REF
export
factor
(ALYREF)
enhance
stability
messenger
RNA
(mRNA)
via
m5C
modification,
which
activation
Hippo
β-catenin
signaling
cells.
Rescue
experiments
showed
LINC01259
promoted
progression
YAP1-
ALYREF-dependent
manner.
conclusion,
plays
an
oncogenic
role
regulating
ALYREF/YAP1
signaling,
it
has
be
utilized
diagnostic
marker
therapeutic
NSCLC.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: May 12, 2023
RNA
modifications
are
important
regulators
of
transcript
activity
and
an
increasingly
emerging
body
data
suggests
that
the
epitranscriptome
its
associated
enzymes
altered
in
human
tumors.
International Journal of Biological Sciences,
Journal Year:
2023,
Volume and Issue:
19(4), P. 1146 - 1162
Published: Jan. 1, 2023
tRNA
is
one
of
the
most
conserved
and
abundant
RNA
species,
which
plays
a
key
role
during
protein
translation.tRNA
molecules
are
post-transcriptionally
modified
by
modifying
enzymes.Since
high-throughput
sequencing
technology
has
developed
rapidly,
modification
types
have
been
discovered
in
many
research
fields.In
tRNA,
numerous
modifications
enzymes
implicated
biological
functions
human
diseases.In
our
review,
we
talk
about
relevant
modifications,
including
stability,
translation,
cell
cycle,
oxidative
stress,
immunity.We
also
explore
how
contribute
to
progression
diseases.Based
on
previous
studies,
discuss
some
emerging
techniques
for
assessing
aid
discovering
different
modifications.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3098 - 3098
Published: March 7, 2024
Epitranscriptomic
mechanisms,
which
constitute
an
important
layer
in
post-transcriptional
gene
regulation,
are
involved
numerous
cellular
processes
under
health
and
disease
such
as
stem
cell
development
or
cancer.
Among
various
RNA
methylation
is
considered
to
have
vital
roles
eukaryotes
primarily
due
its
dynamic
reversible
nature.
There
methylations
that
include,
but
not
limited
to,
2'-O-dimethyladenosine
(m6Am),
N7-methylguanosine
(m7G),
N6-methyladenosine
(m6A)
N1-methyladenosine
(m1A).
These
biochemical
modifications
modulate
the
fate
of
by
affecting
translation,
target
site
determination,
processing,
polyadenylation,
splicing,
structure,
editing
stability.
Thus,
it
highly
quantitatively
measure
changes
marks
gain
insight
into
disease.
Although
there
complicating
challenges
identifying
certain
genome
wide,
methods
been
developed
recently
facilitate
quantitative
measurement
methylated
RNAs.
To
this
end,
detection
for
can
be
classified
five
categories
antibody-based,
digestion-based,
ligation-based,
hybridization-based
direct
RNA-based
methods.
In
review,
we
aimed
summarize
our
current
understanding
methylation,
highlighting
their
advantages
disadvantages,
along
with
field.
Experimental & Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
56(6), P. 1235 - 1249
Published: June 14, 2024
It
is
apparent
that
various
functional
units
within
the
cellular
machinery
are
derived
from
RNAs.
The
evolution
of
sequencing
techniques
has
resulted
in
significant
insights
into
approaches
for
transcriptome
studies.
Organisms
utilize
RNA
to
govern
systems,
and
a
heterogeneous
class
RNAs
involved
regulatory
functions.
In
particular,
increasingly
recognized
participate
intricately
functioning
across
almost
all
levels
biological
systems.
These
systems
include
those
mediating
chromatin
arrangement,
transcription,
suborganelle
stabilization,
posttranscriptional
modifications.
Any
exhibiting
activity
can
be
termed
typically
represented
by
noncoding
RNAs,
which
constitute
substantial
portion
genome.
function
based
on
principle
structural
changes
through
cis
and/or
trans
regulation
facilitate
mutual
RNA‒RNA,
RNA‒DNA,
RNA‒protein
interactions.
not
been
clearly
elucidated
whether
identified
deep
actually
anticipated
mechanisms.
This
review
addresses
dominant
properties
at
layers
covers
activities,
dynamics,
modifications,
associated
molecules,
further
challenges
related
therapeutics
learning.
Cell Death Discovery,
Journal Year:
2024,
Volume and Issue:
10(1)
Published: Feb. 14, 2024
Long
noncoding
RNAs
(lncRNAs)
are
a
group
of
with
transcript
lengths
>200
nucleotides.
Mounting
evidence
suggests
that
lncRNAs
closely
associated
tumorigenesis.
LncRNA
H19
(H19)
was
the
first
lncRNA
to
function
as
an
oncogene
in
many
malignant
tumors.
Apart
from
established
role
promoting
cell
growth,
proliferation,
invasion,
migration,
epithelial-mesenchymal
transition
(EMT),
and
metastasis,
it
has
been
recently
discovered
also
inhibits
programmed
death
(PCD)
cancer
cells.
In
this
review,
we
summarize
mechanisms
by
which
regulates
PCD
cells
through
various
signaling
pathways,
molecular
mechanisms,
epigenetic
modifications.
Wnt/β-catenin
pathway
PI3K-Akt-mTOR
pathway.
It
acts
competitive
endogenous
RNA
(ceRNA)
regulation.
The
interaction
between
RNA-binding
proteins
(RBP)
apoptosis
cancer.
Moreover,
modifications,
including
DNA
methylation
histone
involved
H19-associated
conclusion,
via
chemoresistance,
highlighting
promising
research
significance
therapeutic
target.
We
hope
our
study
will
contribute
broader
understanding
development
treatment.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
Abstract
The
relationship
between
patterns
of
RNA
modifications
and
gastric
cancer
(GC)
liver
metastasis
(GCLM)
remains
unclear.
Here,
by
single‐cell
sequencing,
clinical
sample
analysis,
mouse
model
studies,
an
abnormal
increase
in
the
expression
acetyltransferase
N‐acetyltransferase
10
(NAT10)
metastatic
GC
cells
is
identified.
NAT10‐mediated
N4‐acetylcytidine
modification
CXCL2
KLF5
mRNA
increases
their
stability.
Then,
secreted
found
to
promote
infiltration
polarization
M2‐like
macrophages
produce
oncostatin
M,
which
transcriptionally
activates
NAT10
via
STAT3
signaling.
In
addition,
organoid
models
confirm
that
promotes
adhesion
hepatocytes.
Mechanistically,
ITGαV,
facilitating
cell
attachment
Intriguingly,
high
NAT10/KLF5
axis
associated
with
poor
prognosis
patients
targeting
this
significantly
reduces
GCLM
preclinical
murine
models.
Collectively,
these
findings
suggest
significance
developing
targeted
therapies
for
metastasis.